The investigation provides a potential strategy to enhance chemotherapeutic efficacy by blocking the EV miRNA-OC-2 axis, but the role of OC-2 in breast cancer development and gene therapy has not been clarified. Here, ONECUT2 is linked to breast carcinoma.